| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/12/1998 | WO1998005776A2 Secreted proteins and polynucleotides encoding them |
| 02/12/1998 | WO1998005684A2 Mhc binding peptide oligomers and methods of use |
| 02/12/1998 | WO1998005635A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 02/12/1998 | WO1998005361A2 Long-acting drugs and pharmaceutical compositions comprising them |
| 02/12/1998 | WO1998005357A1 Anti-tnf antibodies and methotrexate in the treatment of autoimmune disease |
| 02/12/1998 | WO1998005333A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 02/12/1998 | WO1998005317A1 Il-8 receptor antagonists |
| 02/12/1998 | CA2791778A1 Anti-tnf antibodies and methotrexate in the treatment of autoimmune disease |
| 02/12/1998 | CA2263154A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 02/12/1998 | CA2262900A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 02/12/1998 | CA2262415A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 02/12/1998 | CA2262405A1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis |
| 02/12/1998 | CA2262401A1 Secreted proteins and polynucleotides encoding them |
| 02/12/1998 | CA2262399A1 Secreted proteins and polynucleotides encoding them |
| 02/12/1998 | CA2212711A1 Immunoassay method |
| 02/11/1998 | EP0822986A1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds |
| 02/11/1998 | EP0822984A1 Human tumor necrosis factor receptors |
| 02/11/1998 | EP0822983A1 Apopain |
| 02/11/1998 | EP0822832A1 Cd45rb binding compounds for the prevention of transplant rejection |
| 02/11/1998 | EP0822831A1 Vaccines containing a saponin and a sterol |
| 02/11/1998 | EP0822817A1 Use of (r)-penciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases |
| 02/11/1998 | CN1173184A Identitication, purification and uses of leczymes and carbohydrate ligands |
| 02/11/1998 | CN1173183A Conjugates of BDNF and NT-3 with a water-soluble polymer |
| 02/11/1998 | CN1173178A Imidazo £ 4, 5-c| quinoleine amines |
| 02/10/1998 | US5717073 Anti-gp130 monoclonal antibodies |
| 02/10/1998 | US5717072 For suppressing immune or inflammatory response in mammals |
| 02/10/1998 | US5716986 Lipoxygenase inhibitors |
| 02/10/1998 | US5716979 Tachykinin antagonists |
| 02/10/1998 | US5716967 Isoxazoline compounds as antiinflammatory agents |
| 02/10/1998 | US5716959 Administering substituted piperazines having hydroxy- or amino-alkyl groups on one nitrogen and carboxylic, phosphoric or sulfonic alkyl groups on the other nitrogen, for treatment of cancer and autoimmune diseases |
| 02/10/1998 | US5716955 Cytokine inhibitor |
| 02/10/1998 | US5716946 Multiple sclerosis treatment |
| 02/10/1998 | US5716945 Antiinflammatory agents; immunostimulation; cell differentiation; antigrowth agents |
| 02/10/1998 | US5716930 Polypeptide from genetically engineered cells |
| 02/10/1998 | US5716929 Inhibitors of interleukin-1β converting enzyme |
| 02/05/1998 | WO1998004913A1 Molecular model for vla-4 inhibitors |
| 02/05/1998 | WO1998004720A1 Method and reagents for genetic immunization |
| 02/05/1998 | WO1998004718A1 Fusion polypeptides comprising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
| 02/05/1998 | WO1998004694A2 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | WO1998004693A2 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | WO1998004585A2 Novel human macrophage antigen |
| 02/05/1998 | WO1998004582A1 Isolated peptides derived from mage-2 |
| 02/05/1998 | WO1998004555A1 Non-symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis |
| 02/05/1998 | WO1998004508A1 NOVEL p-TERPHENYL COMPOUNDS |
| 02/05/1998 | WO1998004285A1 Identification of human cytomegalovirus genes involved in down-regulation of mhc class i heavy chain expression |
| 02/05/1998 | WO1998004284A1 Novel genes of kaposi's sarcoma associated herpesvirus |
| 02/05/1998 | WO1998004281A1 Improved method of treating immune cell mediated systemic diseases |
| 02/05/1998 | WO1998004279A1 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin |
| 02/05/1998 | WO1998004276A1 Use in a composition of an extract of at least one labiate |
| 02/05/1998 | WO1998004275A1 Preparation of immunostimulating agents based on propionibacteria |
| 02/05/1998 | WO1998004270A1 Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition |
| 02/05/1998 | WO1998004247A1 Cell adhesion inhibitors |
| 02/05/1998 | WO1997048368A3 Naphthyridines which affect il-4 and g-csf |
| 02/05/1998 | WO1997047744A3 T-cell selective interleukin-4 agonists |
| 02/05/1998 | WO1997040069A3 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | WO1997038084A3 Polynucleotides derived from a pbmc cdna library encoding secreted proteins |
| 02/05/1998 | CA2289699A1 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | CA2262564A1 Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition |
| 02/05/1998 | CA2262006A1 Method and reagents for genetic immunization |
| 02/05/1998 | CA2261991A1 Preparation of immunostimulating agents based on propionibacteria |
| 02/05/1998 | CA2261974A1 Molecular model for vla-4 inhibitors |
| 02/05/1998 | CA2261581A1 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | CA2261575A1 Novel human macrophage antigen |
| 02/05/1998 | CA2261339A1 Novel p-terphenyl compounds |
| 02/05/1998 | CA2258609A1 Non-symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis |
| 02/04/1998 | EP0822255A2 CHO (Chinese Hamster Ovary) glycosylated antibodies and their use in therapy |
| 02/04/1998 | EP0822199A2 N-terminally monopegylated polypeptides and process for their preparation. |
| 02/04/1998 | EP0822186A2 L-tert-leucine-2-pyridylamide |
| 02/04/1998 | EP0821960A1 Use of xanthine derivatives for the modulation of apoptosis |
| 02/04/1998 | EP0821952A1 Use of isoxazole and crotonic acid amide derivatives for the modulation of apoptosis |
| 02/04/1998 | EP0821740A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations |
| 02/04/1998 | EP0821732A1 Altered polypeptides with increased half-life |
| 02/04/1998 | EP0821695A1 Antibody purification by low-ph hydrophobic interaction chromatoggraphy |
| 02/04/1998 | EP0821692A1 Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 02/04/1998 | EP0821691A1 Methods of synthesizing gm2 |
| 02/04/1998 | EP0821671A1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors |
| 02/04/1998 | EP0821669A1 Hydroxamic and carboxylic acids as metalloprotease inhibitors |
| 02/04/1998 | EP0821668A1 Derivatives of succinamide and their use as metalloproteinase inhibitor |
| 02/04/1998 | EP0821666A1 Derivatives of succinamide and their use as metalloproteinase inhibitors |
| 02/04/1998 | EP0821551A1 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor |
| 02/04/1998 | EP0675721B1 Pharmaceutical compositions comprising contignasterol compounds |
| 02/04/1998 | EP0671933B1 Novel uses of il-10 |
| 02/04/1998 | EP0667856B1 Novel vitamin d analogues |
| 02/04/1998 | CN1172483A Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same |
| 02/04/1998 | CN1171965A Tianjing Busuiye medicinal liquid and its preparing method |
| 02/04/1998 | CN1171956A Luxian oral liquor and its preparation method |
| 02/03/1998 | US5714514 2-Cyano-3-mercaptocrotonamides |
| 02/03/1998 | US5714501 Antiallergenic/antiasthmatic agents |
| 02/03/1998 | US5714484 α-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 02/03/1998 | US5714382 Isolated dna encoding feline interferon precursor having specified amino acid sequence |
| 02/03/1998 | US5714143 Use of manganese superoxide dismutase (MN-SOD) for preparing pharmaceutical compositions for low-dose treatment of diseases |
| 02/03/1998 | CA1339660C Derivatives of cyclohexane |
| 01/29/1998 | WO1998003670A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways |
| 01/29/1998 | WO1998003654A2 High-affinity interleukin-4 muteins |
| 01/29/1998 | WO1998003653A2 Method for preparing transgenic non-human mammalian organs for transplantation to humans, and nucleotide sequences therefor |
| 01/29/1998 | WO1998003552A2 A multivalent major histocompatibility complex peptide fusion protein for modulating specific t cell function |
| 01/29/1998 | WO1998003551A1 Cd6 ligand |
| 01/29/1998 | WO1998003550A1 Pasteurization of immunoglobulin solutions |
| 01/29/1998 | WO1998003539A1 G-protein coupled receptor hnfds78 |
| 01/29/1998 | WO1998003511A1 New triazolopurines, method of preparing them and their use as drugs |